2021 Invited Speakers


Torsten Haferlach, MD, PhD 

Prof. Torsten Haferlach is a hematologist and a leading expert in the field of leukemia. While engaging in ground breaking research, the development of new diagnostic tools, and the link to treatment options, he always pushes the boundaries of his chosen field and is now introducing AI in routine workflows of leukemia diagnostics.

In 2005, he set up the Munich Leukemia Laboratory (www.mll.com) with three colleagues from complementary disciplines. Today, with a team of 210 employees, the lab processes over 100,000 blood or bone marrow samples every year and his practice treats more than 5,000 patients. His team contributes to standard and cutting-edge diagnostics in leukemia. Dr. Haferlach has published more than 600 articles with many international collaborators in top ranking, peer-reviewed journals since the lab‘s inception. He has provided major contributions to NGS, including WGS and WTS and several workflows including new AI tools which are are established and accredited in MLL.




Subha Madhavan, PhD, FACMI

Dr. Madhavan is a world-class leader in precision medicine research, health data science, biomedical/clinical research informatics and digital health who is goal-oriented and results-driven. As the Chief Data Scientist at Georgetown Medical Center and as the founding director of the Georgetown Innovation Center for Biomedical Informatics, she has initiated, designed, and successfully executed large, multi-disciplinary national and international biomedical research and innovation programs. More recently, she partnered with the FDA Center for Excellence in Regulatory Science program to develop regulatory grade evidence databases for pharmacogenomics and vaccine safety, as well as novel biomarker-based basket and umbrella trial designs that utilize real world evidence from Electronic Health Records. She initiated the Cloud First program at Georgetown University with Amazon Web Services, which has developed and deployed next generation tools for high dimensional research datasets, including next generation sequencing and de-identified patient datasets alongside AI and ML tools to analyze them rapidly to convert data to actionable knowledge. Dr. Madhavan advises early and mid-stage startups on their R&D and go-to-market strategy for data-related products, primarily in the life sciences and healthcare domains. Her data science research is highly cited and published in high impact journals such as Nature, Clinical Cancer Research, Journal of Clinical Oncology, and the Journal of American Medical Informatics. 

Special Presentation: Genetic Counselor Roles in Somatic and Germline Testing


Lindsey Byrne, MS

Lindsey Byrne received her Master of Science in Human Genetics from Sarah Lawrence College in 2008. She has worked her entire genetic counseling career in the field of cancer genetics and is currently at The Ohio State University where she started and runs the GU cancer genetics clinic, and works on the BAP1 research study. She is highly involved in The OSU Genetic Counseling training program as a course director, supervisor, thesis committee member and on the admissions committee. She is the current President of the Ohio Association of Genetic Counselors, and has been the genetic counselor representative and 2020 past co-chair for the state of Ohio Partners for Cancer Control. She is also actively involved with the National Society of Genetic Counselors as the current co-chair of the Cancer special interest group and chair of the outreach and retention subcommittee in the Membership Committee.                             

Sheila Solomon, MS

Sheila Solomon is a licensed board certified genetic counselor in practice for over twenty years. Sheila graduated from the University of Maryland in Molecular Biology and Genetics. She received her Master of Science in Genetic Counseling from the University of Pittsburgh Graduate School of Public Health.

Sheila has dedicated her career interests to the area of clinical cancer genetics through providing genetic counseling in the clinic setting as well as working with providers and advocates in the industry. Currently, Sheila is employed as a Genomic Specialist at Guardant Health, a liquid biopsy genomic testing laboratory.

Sheila is currently the co-chair of the Cancer Special Interest Group (SIG) of the National Society of Genetic Counselors and has held numerous leadership roles within the SIG and more broadly with NSGC. She has numerous publications and national presentations in the field of clinical cancer genetics.